One of the bases of our crystallization development is effective implementation of novel technologies. In addition to our rich experience in technology utilization, we are skilled at introducing innovative concepts for better fundamental understanding, more efficient process development, or improved process performance.
• Process Analytical Technologies (PAT)
Application of a wide range of PAT tools in the development of API crystallization processes is one of the strengths of
our team. In addition to aiding our developmental efficiency, we provide solutions to challenging problems in
crystallization process by implementing proper PAT tool(s).
• Continuous Processing
As pharmaceutical industry is transforming for high efficiency, the manufacturing of pharmaceutical products are
striving for operational efficiency. Proven in many other industries, continuous manufacturing is desired for both
product quality assurance and operational efficiency. We are skilled in capturing the benefits of continuous
crystallization processes, and ready to develop innovative processes.
bio-equip.cn
Crystal Pharmatech is the first technology-driven, China based contract research organization (CRO) that focuses on materials science and engineering for drug development. We partner with clients to ensure comprehensive solutions for their needs in solid-state research, crystallization process development, and preformulation studies. We guide clients in the discovery and selection of the optimal solid phase for drug development using all aspects of pre-formulation studies, including API process and formulation development, regulatory support and intellectual property protection.
Founded in 2010, Crystal Pharmatech has business relationships with over 60 global pharmaceutical companies. High quality service, a culture of confidentiality, and fast turnaround with cost-effective pricing are our trademarks. As we continue to grow, Crystal Pharmatech will always keep customers our number one priority. We will also continue to be at the forefront of innovation in the field of solid-state chemistry so that our customers can reap the benefits of key discoveries in an ever changing field.
Our Scientific Advisory Board includes global leaders in drug development covering amorphous dispersions, co-crystals, crystallization, solid forms, formulation and pre-formulation. The role of our board is all encompassing while we search for new scientific areas for internal and external projects.
中文
